Regent Pacific's Strategic Partner Obtains Clinical Trial Approval for FORTACIN(TM)
HONG KONG, Feb. 9, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Wanbang Biopharmaceutical...
Deep Longevity, Kai-Fu Lee and Medical Doctors Publish "Artificial Intelligence in Longevity Medicine"
HONG KONG, Jan. 28, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group";SEHK: 0575.HK)'s Deep Longevity, Inc, a company acquired on 14 December 2020 which develops artificial intelligence to track human aging and ext...
Regent Pacific Group Limited Announces the Successful Launch of Fortacin(TM) in Hong Kong, Upcoming Launches in Taiwan and Macau and Related Business Updates
HONG KONG, Jan. 18, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Fortacin™, the Group's ...
Regent Pacific Announces Key Research Findings On FORTACIN™
HONG KONG, Jan. 11, 2021 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce several key findings on the w...
Regent Pacific Announces Key Progresses On FORTACIN(TM) / SENSTEND(TM) - Solution to Premature Ejaculation
CHINA * Regent Pacific received US$0.72 million (approximately HK$5.62 million, (net of 10% PRC withholding tax) from Wanbang Pharmaceutical on29 December 2020 * The Clinical Trial Approval ("CTA") will be obtained from the Center of Drug Evaluation by the end ofQ1 2021 * Regent Pacific to ...
Deep Longevity Adds Three Medical Organizations To Its Growing Longevity Network: Healthy Hire Healthy Retire, International Medical Clinics and Peak 1 Wellness
Hong Kong, Dec. 28, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group";SEHK: 0575.HK)'s Deep Longevity, Inc, a company acquired on 14 December 2020 which develops artificial intelligence to track human aging and ext...
Deep Longevity Publishes the First Human Psychological Aging Clock Using Artificial Intelligence
HONG KONG, Dec. 17, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK: 0575.HK)'s Deep Longevity, Inc, a company developing artificial intelligence to track human aging and extend productive longevity, releas...
Regent Pacific Completes Acquisition of Deep Longevity, Inc
* Expands into the emerging field of artificial intelligence (AI) and longevity medicine * Strengthens shareholder mix by adding experienced longevity and wellness biotechnology investors and entrepreneurs HONG KONG, Dec. 15, 2020 /PRNewswire/ --Regent Pacific Group Limited ("Regent Pacific" ...
Regent Pacific's Commercial Strategic Partner Receives Approval from Taiwan Food and Drug Administration
HONG KONG, Dec. 14, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Orient EuroPharma Co., L...
Regent Pacific's Strategic Partner Receives Approval from NMPA to Submit IND Application
HONG KONG, Dec. 2, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; stock code: 0575.HK), a specialist healthcare, wellness and life sciences investment group is pleased to announce that Wanbang Pharmaceutical...
Deep Longevity Adds Partnership with My Care Express in Merrillville To Add Biomarkers of Aging and Longevity
HONG KONG, Nov. 26, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK)'s Deep Longevity, Inc, a company subject to a conditional acquisition by the Group which is a pioneer in deep biomarkers of aging...
Deep Longevity Launches The First Longevity Medicine Course For Physicians
HONG KONG, Nov. 18, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK)'s Deep Longevity, Inc, a company subject to a conditional acquisition by the Group which is a pioneer in deep biomarkers of aging...
Regent Pacific Announces Important Commercialisation Progress On FORTACIN(TM) / SENSTEND(TM)
MAINLAND CHINA * Regent Pacific to receive a total payment of US$4 million upon the receipt of approval from the National Medical Products Administration (NMPA) for conducting human trial * China is expected to be the single largest market for Sendstend™ UNITED STATES * The Phase II valid...
Deep Longevity and SquareOne Wellness Partner on Deep Biomarkers of Aging and Longevity
HONG KONG, Oct. 28, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK) today announced that Deep Longevity, Inc, a company recently acquired by the Group which is a pioneer in deep biomarkers of agin...
Deep Longevity and Longenesis to Partner on Consent Management Integration and Federated Learning Method Development
HONG KONG, Oct. 23, 2020 /PRNewswire/ -- Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; SEHK:0575.HK) today announced that Deep Longevity, Inc,, a company recently acquired by the Group which mainly engaged in the development of ex...
